NanoVita positions itself as a DeSci protocol focused on combining nanotechnology, AI-driven biological intelligence and real-world health data within an open and transparent infrastructure. The company announced a strategic financing round (amount undisclosed) led by Paramita, Harbor Digital Ventures and Apus Capital. NanoVita previously raised a Seed round from Cryptogram Venture, UDS Space, Candaq Fintech Group and Susie Venture, followed by a Pre-A round led by K24 Ventures, LandScape Capital and WestLabs. The article does not disclose revenue, user metrics, valuation, or detailed financials. NanoVita has presented its fundraising as part of a broader effort to support its stated goal of revolutionizing health research through integration of advanced technologies. No specific product release plans, timelines, or geographic location were provided in the report.

Total raised

$10M

Funding rounds

2

Latest round

Seed

Latest activity

Mar 2026